Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence (Q38239053)

31 August 2017

Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence (English)

1 reference

31 August 2017

1 reference

Jane A Driver

1

1 reference

31 August 2017

12 August 2014

1 reference

31 August 2017

1 reference

31 August 2017

15

1 reference

31 August 2017

6

1 reference

31 August 2017

547-557

1 reference

https://scigraph.springernature.com/pub.10.1007/s10522-014-9523-2

31 August 2017

0 references

cites work

Citron kinase is required for postnatal neurogenesis in the hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Metformin and neoplasia: implications and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The cortical signature of prodromal AD: regional thinning predicts mild AD dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Prevalent overexpression of prolyl isomerase Pin1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

A common biological mechanism in cancer and Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Proteasome inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Alzheimer's as a metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

An inverse-Warburg effect and the origin of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Parkinson's disease and cancer: two wars, one front

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Aging of the brain, entropy, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Proteasome regulators: activators and inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Metformin: taking away the candy for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Atypical cancer pattern in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Common pathogenic pathways in melanoma and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Alzheimer disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Cancer linked to Alzheimer disease but not vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

PIN1 promoter polymorphisms are associated with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Proteasome activator enhances survival of Huntington's disease neuronal model cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Effect of intranasal insulin on cognitive function: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Tumorigenesis and neurodegeneration: two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Multifunctional role of astrocytes as gatekeepers of neuronal energy supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The NetAge database: a compendium of networks for longevity, age-related diseases and associated processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The relationship between cancer and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Variation in the human TP53 gene affects old age survival and cancer mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

The signaling hubs at the crossroad of longevity and age-related disease networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Prevalence and risks of dementia in the Japanese population: RERF's adult health study Hiroshima subjects. Radiation Effects Research Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Alzheimer disease, the two-hit hypothesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

Malignant Melanoma and Other Types of Cancer Preceding Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-014-9523-2

10.1007/S10522-014-9523-2

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

25113739

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

25113739